138
Views
5
CrossRef citations to date
0
Altmetric
ORIGINAL INVESTIGATION

Genetic underpinnings of left superior temporal gyrus thickness in patients with schizophrenia

, , , , , , , , , & show all
Pages 430-440 | Received 23 Feb 2015, Accepted 05 Jun 2015, Published online: 07 Aug 2015

References

  • Altar CA, Hunt RA, Jurata LW, Webster MJ, Derby E, Gallagher P, et al. 2008. Insulin, IGF-1, and muscarinic agonists modulate schizophrenia-associated genes in human neuroblastoma cells. Biol Psychiatry 64:1077–1087.
  • Anderson CA, Pettersson FH, Clarke GM, Cardon LR, Morris AP, Zondervan KT. 2010. Data quality control in genetic case-control association studies. Nat Protoc 5:1564–1573.
  • Andreasen NC. 1983. Scale for the Assessment of Negative Symptoms (SANS). Iowa City: University of Iowa.
  • Andreasen NC. 1984. Scale for the Assessment of Positive Symptoms (SAPS). Iowa City: University of Iowa.
  • Andreasen NC. 1987. Psychiatric Symptoms You Currently Have–Baseline (PSYCH-1 BASE). The University of Iowa
  • Andreasen NC, Flaum M, Arndt S. 1992. The Comprehensive Assessment of Symptoms and History (CASH). An instrument for assessing diagnosis and psychopathology. Arch Gen Psychiatry 49:615–623.
  • Annett M. 1970. A classification of hand preference by association analysis. Br J Psychol 61:303–321.
  • Barta PE, Pearlson GD, Powers RE, Richards SS, Tune LE. 1990. Auditory hallucinations and smaller superior temporal gyral volume in schizophrenia. Am J Psychiatry 147:1457–1462.
  • Braithwaite JJ, Broglia E, Brincat O, Stapley L, Wilkins AJ, Takahashi C. 2013. Signs of increased cortical hyperexcitability selectively associated with spontaneous anomalous bodily experiences in a nonclinical population. Cognit Neuropsychiatry 18:549–573.
  • Brown S, Birtwistle J, Roe L, Thompson C. 1999. The unhealthy lifestyle of people with schizophrenia. Psychol Med 29:697–701.
  • Buckner RL, Head D, Parker J, Fotenos AF, Marcus D, Morris JC, et al. 2004. A unified approach for morphometric and functional data analysis in young, old, and demented adults using automated atlas-based head size normalization: reliability and validation against manual measurement of total intracranial volume. NeuroImage 23:724–738.
  • Chimienti F, Favier A, Seve M. 2005. ZnT-8, a pancreatic beta-cell-specific zinc transporter. Biometals Int J Role Met Ions Biol Biochem Med 18:313–317.
  • Cohen D, De Hert M. 2011. Endogenic and iatrogenic diabetes mellitus in drug-naïve schizophrenia: the role of olanzapine and its place in the psychopharmacological treatment algorithm. Neuropsychopharmacology 36:2368–2369.
  • De Hert M, Schreurs V, Vancampfort D, Van Winkel R. 2009. Metabolic syndrome in people with schizophrenia: a review. World Psychiatry 8:15–22.
  • Desikan RS, Ségonne F, Fischl B, Quinn BT, Dickerson BC, Blacker D, et al. 2006. An automated labeling system for subdividing the human cerebral cortex on MRI scans into gyral based regions of interest. NeuroImage 31:968–980.
  • Dupuis J, Langenberg C, Prokopenko I, Saxena R, Soranzo N, Jackson AU, et al. 2010. New genetic loci implicated in fasting glucose homeostasis and their impact on type 2 diabetes risk. Nat Genet 42:105–116.
  • First MB. 2002. Structured clinical interview for DSM-IV-TR axis I disorders, research version, non-patient edition. New York: New York State Psychiatric Institute.
  • Fischl B, Dale AM. 2000. Measuring the thickness of the human cerebral cortex from magnetic resonance images. Proc Natl Acad Sci 97:11050–11055.
  • Fischl B, Salat DH, Busa E, Albert M, Dieterich M, Haselgrove C, et al. 2002. Whole brain segmentation: automated labeling of neuroanatomical structures in the human brain. Neuron 33: 341–355.
  • Fischl B, Sereno MI, Dale AM. 1999. Cortical surface-based analysis. II: inflation, flattening, and a surface-based coordinate system. NeuroImage 9:195–207.
  • Flaum M, O’Leary DS, Swayze VW 2nd, Miller DD, Arndt S, Andreasen NC. 1995. Symptom dimensions and brain morphology in schizophrenia and related psychotic disorders. J Psychiatr Res 29:261–276.
  • Funk AJ, McCullumsmith RE, Haroutunian V, Meador-Woodruff JH. 2012. Abnormal activity of the MAPK- and cAMP- associated signaling pathways in frontal cortical areas in postmortem brain in schizophrenia. Neuropsychopharmacol Off Publ Am Coll Neuropsychopharmacol 37:896–905.
  • Galasko D, Kwo-On-Yuen PF, Thal L. 1988. Intracranial mass lesions associated with late-onset psychosis and depression. Psychiatr Clin North Am 11:151–166.
  • Gollub RL, Shoemaker JM, King MD, White T, Ehrlich S, Sponheim SR, et al. 2013. The MCIC collection: a shared repository of multi-modal, multi-site brain image data from a clinical investigation of schizophrenia. Neuroinformatics 11: 367–388.
  • Gottesman II, Gould TD. 2003. The endophenotype concept in psychiatry: etymology and strategic intentions. Am J Psychiatry 160:636–645.
  • Green EK, Grozeva D, Jones I, Jones L, Kirov G, Caesar S, et al. 2010. The bipolar disorder risk allele at CACNA1C also confers risk of recurrent major depression and of schizophrenia. Mol Psychiatry 15:1016–1022.
  • Hass J, Walton E, Kirsten H, Liu J, Priebe L, Wolf C, et al. 2013. A genome-wide association study suggests novel loci associated with a schizophrenia-related brain-based phenotype. PloS One 8:e64872.
  • Heiskanen T, Niskanen L, Lyytikäinen R, Saarinen PI, Hintikka J. 2003. Metabolic syndrome in patients with schizophrenia. J Clin Psychiatry 64:575–579.
  • Henderson DC. 2005. Schizophrenia and comorbid metabolic disorders. J Clin Psychiatry 66(Suppl 6):11–20.
  • Hibar DP, Stein JL, Renteria ME, Arias-Vasquez A, Desrivières S, Jahanshad N, et al. 2015. Common genetic variants influence human subcortical brain structures. Nature 520(7546): 224–229.
  • Hirayasu Y, McCarley RW, Salisbury DF, Tanaka S, Kwon JS, Frumin M, et al. 2000. Planum temporale and Heschl gyrus volume reduction in schizophrenia: a magnetic resonance imaging study of first-episode patients. Arch Gen Psychiatry 57:692–699.
  • Hollingshead A. 1965. Two factor index of social position. New Haven: Yale University.
  • Howie BN, Donnelly P, Marchini J. 2009. A flexible and accurate genotype imputation method for the next generation of genome-wide association studies. PLoS Genet 5:e1000529.
  • Ibáñez V Pietrini P, Alexander GE, Furey ML, Teichberg D, Rajapakse JC, et al. 1998. Regional glucose metabolic abnormalities are not the result of atrophy in Alzheimer's disease. Neurology 50(6):1585–1593.
  • Jiang H, Qiao F, Li Z, Zhang Y, Cheng Y, Xu X, et al. 2015. Evaluating the association between CACNA1C rs1006737 and schizophrenia risk: a meta-analysis. Asia-Pac Psychiatry Off J Pac Rim Coll Psychiatr.
  • Jovicich J, Czanner S, Greve D, Haley E, van der Kouwe A, Gollub R, et al. 2006. Reliability in multi-site structural MRI studies: effects of gradient non-linearity correction on phantom and human data. NeuroImage 30:436–443.
  • Jovicich J, Czanner S, Han X, Salat D, van der Kouwe A, Quinn B, et al. 2009. MRI-derived measurements of human subcortical, ventricular and intracranial brain volumes: reliability effects of scan sessions, acquisition sequences, data analyses, scanner upgrade, scanner vendors and field strengths. NeuroImage 46: 177–192.
  • Kanehisa M, Goto S. 2000. KEGG: kyoto encyclopedia of genes and genomes. Nucleic Acids Res 28:27–30.
  • Kanehisa M, Goto S, Sato Y, Kawashima M, Furumichi M, Tanabe M. 2014. Data, information, knowledge and principle: back to metabolism in KEGG. Nucleic Acids Res 42: D199–205.
  • Kasai K, Shenton ME, Salisbury DF, Hirayasu Y, Lee C-U, Ciszewski AA, et al. 2003. Progressive decrease of left superior temporal gyrus gray matter volume in patients with first- episode schizophrenia. Am J Psychiatry 160:156–164.
  • Kohen D. 2004. Diabetes mellitus and schizophrenia: historical perspective. Br J Psychiatry (Suppl 47):S64–66.
  • Laurie CC, Doheny KF, Mirel DB, Pugh EW, Bierut LJ, Bhangale T, et al. 2010. Quality control and quality assurance in genotypic data for genome-wide association studies. Genet Epidemiol 34:591–602.
  • Lesh TA, Tanase C, Geib BR, Niendam TA, Yoon JH, Minzenberg MJ, et al. 2015. A multimodal analysis of antipsychotic effects on brain structure and function in first-episode schizophrenia. JAMA Psychiatry.
  • Lidow MS. 2003. Calcium signaling dysfunction in schizophrenia: a unifying approach. Brain Res Brain Res Rev 43:70–84.
  • Liu JZ, Mcrae AF, Nyholt DR, Medland SE, Wray NR, Brown KM, et al. 2010. A versatile gene-based test for genome-wide association studies. Am J Hum Genet 87:139–145.
  • Liu Y, Li Z, Zhang M, Deng Y, Yi Z, Shi T. 2013. Exploring the pathogenetic association between schizophrenia and type 2 diabetes mellitus diseases based on pathway analysis. BMC Med Genomics 6(Suppl 1):S17.
  • Mark LP, Prost RW, Ulmer JL, Smith MM, Daniels DL, Strottmann JM, et al. 2001. Pictorial review of glutamate excitotoxicity: fundamental concepts for neuroimaging. Am J Neuroradiol 22:1813–1824.
  • Martins-de-Souza D, Gattaz WF, Schmitt A, Novello JC, Marangoni S, Turck CW, et al. 2009. Proteome analysis of schizophrenia patients Wernicke's area reveals an energy metabolism dysregulation. BMC Psychiatry 9:17.
  • McCarley RW, Shenton ME, O’Donnell BF, Faux SF, Kikinis R, Nestor PG, et al. 1993. Auditory P300 abnormalities and left posterior superior temporal gyrus volume reduction in schizophrenia. Arch Gen Psychiatry 50:190–197.
  • McGeer EG, McGeer PL. 1976. Duplication of biochemical changes of Huntington's chorea by intrastriatal injections of glutamic and kainic acids. Nature 263:517–519.
  • Meyer JM, Stahl SM. 2009. The metabolic syndrome and schizophrenia. Acta Psychiatr Scand 119:4–14.
  • Meyer-Lindenberg A, Weinberger DR. 2006. Intermediate phenotypes and genetic mechanisms of psychiatric disorders. Nat Rev Neurosci 7:818–827.
  • Nesvåg R, Lawyer G, Varnäs K, Fjell AM, Walhovd KB, Frigessi A, et al. 2008. Regional thinning of the cerebral cortex in schizophrenia: effects of diagnosis, age and antipsychotic medication. Schizophr Res 98:16–28.
  • Newcomer JW. 2005. Second-generation (atypical) antipsychotics and metabolic effects: a comprehensive literature review. CNS Drugs 19(Suppl 1):1–93.
  • Nicolson TJ, Bellomo EA, Wijesekara N, Loder MK, Baldwin JM, Gyulkhandanyan AV, et al. 2009. Insulin storage and glucose homeostasis in mice null for the granule zinc transporter ZnT8 and studies of the type 2 diabetes-associated variants. Diabetes 58:2070–2083.
  • Ohi K, Hashimoto R, Ikeda M, Yamashita F, Fukunaga M, Nemoto K, et al. 2014. Genetic risk variants of schizophrenia associated with left superior temporal gyrus volume. Cortex 58:23–26.
  • Patterson N, Price AL, Reich D. 2006. Population structure and eigenanalysis. PLoS Genet 2:e190.
  • Pearlson GD. 1997. Superior temporal gyrus and planum temporale in schizophrenia: a selective review. Prog Neuropsychopharmacol Biol Psychiatry 21:1203–1229.
  • Pelphrey KA, Viola RJ, McCarthy G. 2004. When strangers pass: processing of mutual and averted social gaze in the superior temporal sulcus. Psychol Sci 15:598–603.
  • Penfield W, Perot P. 1963. The brain's record of auditory and visual experience. A final summary and discussion. Brain J Neurol 86:595–696.
  • Price AL, Patterson NJ, Plenge RM, Weinblatt ME, Shadick NA, Reich D. 2006. Principal components analysis corrects for stratification in genome-wide association studies. Nat Genet 38:904–909.
  • Price AL, Weale ME, Patterson N, Myers SR, Need AC, Shianna KV, et al. 2008. Long-range LD can confound genome scans in admixed populations. Am J Hum Genet 83:132–135.
  • Purcell SM, Moran JL, Fromer M, Ruderfer D, Solovieff N, Roussos P, et al. 2014. A polygenic burden of rare disruptive mutations in schizophrenia. Nature 506:185–190.
  • Purcell S, Neale B, Todd-Brown K, Thomas L, Ferreira MAR, Bender D, et al. 2007. PLINK: a tool set for whole-genome association and population-based linkage analyses. Am J Hum Genet 81:559–575.
  • Rees E, O’Donovan MC, Owen MJ. 2015. Genetics of schizophrenia. Curr Opin Behav Sci 2:8–14.
  • Rimol LM, Hartberg CB, Nesvåg R, Fennema-Notestine C, Hagler DJ, Pung CJ, et al. 2010. Cortical thickness and subcortical volumes in schizophrenia and bipolar disorder. Biol Psychiatry 68:41–50.
  • Ruchat S-M, Elks CE, Loos RJF., Vohl M-C, Weisnagel SJ, Rankinen T, et al. 2009. Association between insulin secretion, insulin sensitivity and type 2 diabetes susceptibility variants identified in genome-wide association studies. Acta Diabetol 46:217–226.
  • Schizophrenia Working Group of the Psychiatric Genomics Consortium 2014. Biological insights from 108 schizophrenia- associated genetic loci. Nature 511:421–427.
  • Sladek R, Rocheleau G, Rung J, Dina C, Shen L, Serre D, et al. 2007. A genome-wide association study identifies novel risk loci for type 2 diabetes. Nature 445:881–885.
  • Strawbridge RJ, Dupuis J, Prokopenko I, Barker A, Ahlqvist E, Rybin D, et al. 2011. Genome-wide association identifies nine common variants associated with fasting proinsulin levels and provides new insights into the pathophysiology of Type 2. Diabetes 60:2624–2634.
  • Tang J, Liao Y, Zhou B, Tan C, Liu W, Wang D, et al. 2012. Decrease in temporal gyrus gray matter volume in first-episode, early onset schizophrenia: an MRI study. PloS One 7:e40247.
  • Teo YY. 2008. Common statistical issues in genome-wide association studies: a review on power, data quality control, genotype calling and population structure. Curr Opin Lipidol 19:133–143.
  • Van Haren NEM, Schnack HG, Cahn W, van den Heuvel MP, Lepage C, Collins L, et al. 2011. Changes in cortical thickness during the course of illness in schizophrenia. Arch Gen Psychiatry 68:871–880.
  • Verma SK, Subramaniam M, Liew A, Poon LY. 2009. Metabolic risk factors in drug-naive patients with first-episode psychosis. J Clin Psychiatry 70:997–1000.
  • Verweij KJH, Zietsch BP, Medland SE, Gordon SD, Benyamin B, Nyholt DR, et al. 2010. A genome-wide association study of Cloninger's temperament scales: implications for the evolutionary genetics of personality. Biol Psychol 85:306–317.
  • Voight BF, Scott LJ, Steinthorsdottir V, Morris AP, Dina C, Welch RP, et al. 2010. Twelve type 2 diabetes susceptibility loci identified through large-scale association analysis. Nat Genet 42:579–589.
  • World Health Organization 2008. The global burden of disease: 2004 update (WHO Press).
  • Wilkison G. 1993. Wide range achievement test. 3rd ed. Wilmington: Wide Range, Inc.
  • Winkler AM, Kochunov P, Blangero J, Almasy L, Zilles K, Fox PT, et al. 2010. Cortical thickness or grey matter volume? The importance of selecting the phenotype for imaging genetics studies. NeuroImage 53:1135–1146.
  • Wood D, King M, Landis D, Courtney W, Wang R, Kelly R, et al. 2014. Harnessing modern web application technology to create intuitive and efficient data visualization and sharing tools. Front Neuroinformatics 8.
  • Woods S. 2003. Chlorpromazine equivalent doses for the newer atypical antipsychotics. J Clin Psychiatry 64:663–667.
  • Yoshida T, McCarley RW, Nakamura M, Lee K, Koo M-S, Bouix S, et al. 2009. A prospective longitudinal volumetric MRI study of superior temporal gyrus gray matter and amygdala-hippocampal complex in chronic schizophrenia. Schizophr Res 113:84–94.
  • Yoshii F, Barker WW, Chang JY, Loewenstein D, Apicella A, Smith D, et al. 1988. Sensitivity of cerebral glucose metabolism to age, gender, brain volume, brain atrophy, and cerebrovascular risk factors. J Cereb Blood Flow Metab 8(5):654–661.
  • Zheng W, Wang H, Zeng Z, Lin J, Little PJ, Srivastava LK, et al. 2012. The possible role of the Akt signaling pathway in schizophrenia. Brain Res 1470:145–158.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.